TDNA
T. Rowe Price Biotech ETF
$25.60
T. Rowe Price Biotech ETF (TDNA) Price & Chart
TDNA ETF Chart & Stats
$25.60
At close: 4:00 PM EST- Day’s Range
- $25.60 - $25.60
- 52-Week Range
- $22.72 - $25.68
- Previous Close
- $25.49
- Volume
- 223
- Average Volume (3M)
- 2,192
- AUM
- 11.54M
- NAV
- 25.46
- Expense Ratio
- 0.55%
- Holdings Count
- 87
- Beta
- 0.36
- Inception Date
- Sep 16, 2026
- Last Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
- Shares Outstanding
- 450,000
- Standard Deviation
- N/A
ETF Overview
T. Rowe Price Biotech ETF
T. Rowe Price Biotech ETF (TDNA) is an actively managed, sector-focused fund investing primarily in global biotechnology companies. Within the Health Care category, it targets the biotechnology niche, seeking exposure to businesses developing innovative medicines, therapies, and related life-science technologies. T. Rowe Price’s investment team uses fundamental, bottom-up research to evaluate companies’ scientific potential, product pipelines, competitive advantages, and financial prospects, with the goal of achieving long-term capital appreciation.
- Asset Class
- Equity
- Region
- Global
- Issuer
- T. Rowe Price
- Index Tracked
- No Underlying Index
- Ticker Symbol
- TDNA
TDNA ETF News
Praxis Precision Medicines: Late-Stage Pipeline and Regulatory Catalysts Support Buy Rating
JonesTrading analyst Justin Walsh has reiterated their bullish stance on PRAX stock, giving a Buy rating today. Justin Walsh gave his rating based on several factors, including continued execution across
1d agoPRAX
TDNA ETF FAQ
What was TDNA’s price range in the past 12 months?
TDNA’s lowest price in the past 12 months was $22.72 and its highest was $25.68.
What is the AUM of TDNA?
As of Nov 10, 2026, the AUM of TDNA is $11.54M.
Is TDNA overvalued?
Based on Wall Street analyst price targets for TDNA’s holdings, TDNA’s price is currently undervalued.
How many shares outstanding does TDNA have?
TDNA has 450,000 shares outstanding.
TDNA ETF Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| ARGXArgenx | 5.40% |
| KYMRKymera Therapeutics, Inc. | 4.87% |
| KODKodiak Sciences | 3.07% |
| INSMInsmed | 2.68% |
| MRNAModerna | 2.44% |
| PCVXVaxcyte, Inc. | 2.33% |
| RYTMRhythm Pharmaceuticals | 2.23% |
| PRAXPraxis Precision Medicines, Inc. | 2.22% |
| RVMDRevolution Medicines, Inc. | 2.20% |
| UTHRUnited Therapeutics Corp. | 2.12% |
| Total | 29.57% |
